Aura Biosciences (AURA) Other Non-Current Liabilities (2020 - 2022)

Aura Biosciences has reported Other Non-Current Liabilities for 3 years, with the latest figure at $67000.0 in Q2 2022.

• For the quarter ending Q2 2022, Other Non-Current Liabilities changed N/A year-over-year to $67000.0; the trailing twelve-month figure through Jun 2022 stood at $67000.0 (changed N/A YoY), and the FY2021 full-year result was $83000.0, up 15.28% from the prior year.
• Other Non-Current Liabilities for Q2 2022 stood at $67000.0, down from $127000.0 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $127000.0 in Q1 2022, with the low at $67000.0 in Q2 2022.
• Historically, Other Non-Current Liabilities has averaged $84000.0 across 3 years, with a median of $72000.0 in 2020.
• The largest YoY upside for Other Non-Current Liabilities was 15.28% in 2021 against a maximum downside of 15.28% in 2021.
• Aura Biosciences' Other Non-Current Liabilities stood at $72000.0 in 2020, then grew by 15.28% to $83000.0 in 2021, then decreased by 19.28% to $67000.0 in 2022.
• The last three Other Non-Current Liabilities figures came in at $67000.0 (Q2 2022), $127000.0 (Q1 2022), and $83000.0 (Q4 2021), per Business Quant data.